We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.4%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
–
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
101.89%
Top 10 Holdings %
Top 10 Hldgs %
12.2%
Holding
422
New
422
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$18.9M |
| 2 |
AGN
Allergan Inc
AGN
|
+$18.6M |
| 3 |
Pfizer
PFE
|
+$18.6M |
| 4 |
Western Digital
WDC
|
+$15.4M |
| 5 |
SHPG
Shire pic
SHPG
|
+$15.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.26% |
| 2 | Consumer Discretionary | 12.33% |
| 3 | Technology | 11.82% |
| 4 | Industrials | 10.72% |
| 5 | Financials | 9.25% |
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Marshall Wace North America, which disclosed 422 positions worth $1.27B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Eli Lilly: 347,198 shares worth $17.1M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, followed by Consumer Discretionary and Technology.
- Marshall Wace North America's largest Q2 2013 buy was Eli Lilly: 347,198 shares worth $17.1M.
- Marshall Wace North America's ten largest holdings make up 12% of its $1.27B portfolio in Q2 2013.
- Marshall Wace North America disclosed 422 positions in Q2 2013, its first 13F filing on record.
Based on Marshall Wace North America's 13F filing for Q2 2013, filed 6 Aug 2013.